SALIX PHARMACEUTICALS LTD DEL
SLXP
SLXP was delisted on the 31st of March, 2015.
298 hedge funds and large institutions have $10.8B invested in SALIX PHARMACEUTICALS LTD DEL in 2015 Q1 according to their latest regulatory filings, with 87 funds opening new positions, 77 increasing their positions, 115 reducing their positions, and 130 closing their positions.
236% more funds holding in top 10
Funds holding in top 10: 14 → 47 (+33)
147% more call options, than puts
Call options by funds: $3.77B | Put options by funds: $1.52B
36% more capital invested
Capital invested by funds: $7.99B → $10.8B (+$2.84B)
14% less funds holding
Funds holding: 346 → 298 (-48)
33% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 115
33% less first-time investments, than exits
New positions opened: 87 | Existing positions closed: 130
Top Buyers
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$333M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$213M |
| 3 |
MCM
Mason Capital Management
New York
|
+$203M |
| 4 |
HP
Hound Partners
New York
|
+$196M |
| 5 |
SC
Sculptor Capital
New York
|
+$181M |
Top Sellers
| 1 |
VAM
Visium Asset Management
New York
|
-$354M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$344M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$200M |
| 4 |
O
OppenheimerFunds
New York
|
-$174M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$170M |
SLXP Hedge Fund Activity: Q1 2015 in Review
298 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q1 2015, worth a combined $10.8B — up 36% from $7.99B a quarter earlier.
Sellers outnumbered buyers: 130 funds closed out of SLXP and 87 opened new positions — a net loss of 43 holders — while 115 trimmed existing stakes and 77 added.
The largest buyer was Pentwater Capital Management, adding an estimated $333M. The largest seller was Visium Asset Management, exiting entirely with an estimated $354M sold.
- 298 institutional investors held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q1 2015, down from 346 in Q4 2014.
- Funds reported $10.8B of SALIX PHARMACEUTICALS LTD DEL stock for Q1 2015, up 36% quarter-over-quarter.
- 87 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q1 2015 and 130 closed out, a net change of -43 holders.
- The largest SALIX PHARMACEUTICALS LTD DEL buyer in Q1 2015 was Pentwater Capital Management, an estimated $333M added.
- The largest SALIX PHARMACEUTICALS LTD DEL seller in Q1 2015 was Visium Asset Management, an estimated $354M sold.
Based on aggregated 13F filings for Q1 2015.